Not Yet RecruitingNot Applicable

Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD

200 participantsStarted 2026-11-01

Plain-language summary

To evaluate the efficacy of Essential phospholipid versus Betaine HCL/L-Glutamic Acid in MAFLD

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients aged \>18 years old * diagnosed as fatty liver based on clinical examination, laboratory investigations and imaging techniques. Exclusion Criteria: * Patients aged ≤18 years old. * Pregnancy. * Presence of malignancy. * Type I DM. * Fatty liver patients on treatment by statin derivatives or other medications. * Fatty liver patients undergone bariatric surgeries

What they're measuring

evaluate the efficacy of Essential phospholipid versus Betaine HCL/L-Glutamic Acid in MAFLD

Timeframe: Baseline and at 12 weeks of treatment

Trial details

NCT IDNCT07194863

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11-01

Contact for this trial

Amira M. Abdelmawgod, MD, PhD

+201012760437 amiramohmad60@gmail.com

View on ClinicalTrials.gov More Essential Phospholipid in Metabolic Associated Fatty Liver Disease trials